Altogether, these results show that a single immunization with IDLV-OVA induced a strong, persistent, and functional CD8+ T cell-mediated OVA-specific response able to eradicate a preexisting large tumor mass as well as to generate memory cells able to prevent potential relapses. The gene discussed is CD8A; the disease is neoplasm.